Stay updated on VenDex vs PomDex in t(11;14)+ MM Clinical Trial
Sign up to get notified when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.

Latest updates to the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page
- Check4 days agoChange DetectedA small update to the site's revision history was made, adding Revision: v3.4.1 and removing Revision: v3.4.0, reflecting internal version control rather than changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoChange DetectedRemoved 'Multiple Myeloma' and 'MedlinePlus Genetics' from the study page's related topics/keywords. This change removes metadata without altering core trial content or patient information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedThe additions introduce a glossary display and related topics, such as Multiple Myeloma and MedlinePlus Genetics, and include visibility of QC-related metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). These changes are minor UI/metadata updates that do not affect core trial content, eligibility, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check25 days agoChange DetectedThe page now shows Revision: v3.3.4 added, and related topics such as Multiple myeloma and MedlinePlus Genetics, plus the prior revision tag v3.3.3, were removed. The main study details and content remain unchanged.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now displays related topics: ‘Multiple myeloma’ under MedlinePlus Genetics, providing additional contextual navigation. This is a minor informational enhancement that does not alter the study details themselves.SummaryDifference0.1%

- Check53 days agoChange DetectedThe Locations section now lists a broad set of study sites across the United States, Canada, Europe, and other regions, expanding the geographic footprint of the trial.SummaryDifference4%

Stay in the know with updates to VenDex vs PomDex in t(11;14)+ MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VenDex vs PomDex in t(11;14)+ MM Clinical Trial page.